Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Treatment begins in phase III trial of Litx for metastatic colorectal cancer

July 20, 2007

Millennium begins phase III trial of Velcade for newly diagnosed MM

July 19, 2007

Aquinox describes development of SHIP inhibitor MN-100

July 19, 2007

Nerviano presents first Cdc7 kinase inhibitors

July 18, 2007

First launch for Torisel

July 18, 2007

Update on Antisoma's phase II trial of ASA-404 for ovarian cancer

July 18, 2007

RON receptor tyrosine kinase a potential pancreatic cancer target

July 17, 2007

ERCC1 mRNA measurement used to assign non-small cell lung cancer treatment

July 17, 2007

Ariad and Merck & Co. enter global collaboration to jointly develop and market AP-23573

July 17, 2007

Outcome of Erbitux phase III study in first-line treatment of advanced lung cancer

July 17, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...